Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme
- PMID: 8784355
- DOI: 10.1038/nsb0996-803
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme
Abstract
The Camelidae is the only taxonomic family known to possess functional heavy-chain antibodies, lacking light chains. We report here the 2.5 A resolution crystal structure of a camel VH in complex with its antigen, lysozyme. Compared to human and mouse VH domains, there are no major backbone rearrangements in the VH framework. However, the architecture of the region of VH that interacts with a VL in a conventional FV is different from any previously seen. Moreover, the CDR1 region, although in sequence homologous to human CDR1, deviates fundamentally from the canonical structure. Additionally, one half of the CDR3 contacts the VH region which in conventional immunoglobulins interacts with a VL whereas the other half protrudes from the antigen binding site and penetrates deeply into the active site of lysozyme.
Comment in
-
Redefining the minimal antigen-binding fragment.Nat Struct Biol. 1996 Sep;3(9):733-6. doi: 10.1038/nsb0996-733. Nat Struct Biol. 1996. PMID: 8784342 No abstract available.
Similar articles
-
Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains.Protein Eng. 1994 Sep;7(9):1129-35. doi: 10.1093/protein/7.9.1129. Protein Eng. 1994. PMID: 7831284
-
A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.Structure. 1999 Apr 15;7(4):361-70. doi: 10.1016/s0969-2126(99)80049-5. Structure. 1999. PMID: 10196124
-
The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3.Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9637-42. doi: 10.1073/pnas.94.18.9637. Proc Natl Acad Sci U S A. 1997. PMID: 9275175 Free PMC article.
-
Single domain antibodies: comparison of camel VH and camelised human VH domains.J Immunol Methods. 1999 Dec 10;231(1-2):25-38. doi: 10.1016/s0022-1759(99)00138-6. J Immunol Methods. 1999. PMID: 10648925 Review.
-
Single domain camel antibodies: current status.J Biotechnol. 2001 Jun;74(4):277-302. doi: 10.1016/s1389-0352(01)00021-6. J Biotechnol. 2001. PMID: 11526908 Review.
Cited by
-
Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species.Front Immunol. 2024 Jan 30;15:1346328. doi: 10.3389/fimmu.2024.1346328. eCollection 2024. Front Immunol. 2024. PMID: 38352869 Free PMC article.
-
Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies.Cancer Cell Int. 2024 Feb 10;24(1):67. doi: 10.1186/s12935-024-03259-8. Cancer Cell Int. 2024. PMID: 38341580 Free PMC article. Review.
-
Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management.Cancers (Basel). 2024 Jan 15;16(2):371. doi: 10.3390/cancers16020371. Cancers (Basel). 2024. PMID: 38254860 Free PMC article. Review.
-
γδ T cell antigen receptor polyspecificity enables T cell responses to a broad range of immune challenges.Proc Natl Acad Sci U S A. 2024 Jan 23;121(4):e2315592121. doi: 10.1073/pnas.2315592121. Epub 2024 Jan 16. Proc Natl Acad Sci U S A. 2024. PMID: 38227652 Free PMC article.
-
The immunoglobulin A isotype of the Arabian camel (Camelus dromedarius) preserves the dualistic structure of unconventional single-domain and canonical heavy chains.Front Immunol. 2023 Dec 12;14:1289769. doi: 10.3389/fimmu.2023.1289769. eCollection 2023. Front Immunol. 2023. PMID: 38162642 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases